Skip to main content
Premium Trial:

Request an Annual Quote

SomaLogic to Provide Reagents for New England Biolabs' PCR Products

Premium

SomaLogic will provide New England Biolabs with protein-binding reagents for use in NEB's nucleic acid amplification and PCR products, under an agreement announced today by the companies.

Terms of the deal fall for Boulder, Colo.-based SomaLogic to provide specific SomaMers — protein-binding reagents based on chemically modified aptamers — to NEB, which will incorporate them into its products as reversible inhibitors of its thermally active DNA polymerases for PCR, such as its OneTaq Hot Start DNA polymerase.

In a statement, Salvatore Russello, associate director of business development at Ipswich, Mass.-based NEB, said that there are "many opportunities to further enhance the performance of thermally active DNA polymerase in PCR reactions. This agreement is thus of great value to NEB and is already being used to improve the application of DNA polymerases, such as OneTaq Hot Start."

Financial and other terms of the agreement were not disclosed.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.